Pulmonary DiseaseNCT05871710
Validity and Reliability of the Turkish Version of the Tele-Pulmonary Rehabilitation Acceptance Scale
An observational study of Pulmonary Disease and Telehealth, run by Uskudar State Hospital.
Trial summary
The objective of this research is to translate the Tele-Pulmonary Rehabilitation Acceptance Scale into Turkish and assess its reliability and accuracy. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Pulmonary Disease, Telehealth, Pulmonary Rehabilitation
- What is being tested?
- Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale and Scale Evaluation Form
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2023to 1 Mar 2024
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Native Turkish-speaking patients in need of pulmonary rehabilitation and native Turkish-speaking healthcare professionals working in the field of pulmonary rehabilitation.
Who may be able to join
- Being a patient in need of pulmonary rehabilitation or a healthcare professional working in the field of pulmonary rehabilitation.
- Being a native Turkish speaker.
- Giving consent to participate in the study.
Who cannot join
- Any disease or condition that prevents reading, understanding, or filling out forms.
- Not giving consent to participate in the study.
Trial locations and contacts
No sites are listed yet.
About this study
The objective of this research is to translate the Tele-Pulmonary Rehabilitation Acceptance Scale into Turkish and assess its reliability and accuracy.
Read the detailed description
The use of telehealth in pulmonary rehabilitation, also known as telerehabilitation, is a novel approach in healthcare practice. In order to effectively implement telerehabilitation programs, it is important to evaluate how potential users perceive and accept this new type of program. Thus, the aim of this research was to create a measuring tool that could assess the level of acceptance of telerehabilitation among healthcare providers and patients. A group of experts in pulmonary rehabilitation, telehealth, information technology, and scale development have reviewed and confirmed the content validity of the Tele-Pulmonary Rehabilitation Acceptance Scale. This scale is significant because it offers a consistent means of collecting data to measure the level of acceptance towards telerehabilitation among potential users. This study aims to translate and show the consistency and validity of the Tele-Pulmonary Rehabilitation Acceptance Scale in Turkish.
- Conditions
- Pulmonary Disease, Telehealth, Pulmonary Rehabilitation
- Being tested
- Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale, Scale Evaluation Form
- Medical subject headings
- Lung Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Turkish version of the Tele-Pulmonary Rehabilitation Acceptance ScaleOther
The Tele-Pulmonary Rehabilitation Acceptance Scale is a measuring tool that assesses the level of acceptance towards telerehabilitation programs among healthcare providers and patients in the field of pulmonary rehabilitation. It is used to evaluate the attitudes, beliefs, and perceptions of potential users towards telerehabilitation, which is a form of healthcare delivery that utilizes telecommunication technology to provide remote rehabilitation services to patients. The scale is intended to provide a standardized data collection tool that can be used to measure the level of acceptance of telerehabilitation programs among different groups of potential users. This scale will be translated into Turkish by a researcher who has an advanced level of knowledge in English and whose native language is Turkish.
Scale Evaluation FormOther
The healthcare providers and the patients will be asked about their opinions on the scale's construction, usefulness, and scope using a 100 mm visual analog scale.
| Study group | Role | What they receive |
|---|---|---|
| Patients in need of pulmonary rehabilitation or already receiving pulmonary rehabilitation. | Native Turkish-speaking patients in need of pulmonary rehabilitation or already receiving pulmonary rehabilitation. Receives: Other: Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale; Other: Scale Evaluation Form | |
| Health personnel working in the field of pulmonary rehabilitation. | Native Turkish-speaking health personnel working in the field of pulmonary rehabilitation. Receives: Other: Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale; Other: Scale Evaluation Form |
What is being measured
The primary outcome is the main question the study is designed to answer.
Validity and reliability of the Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale
The primary outcome is the overall validity and reliability of the Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale. This scale is a Likert scale with a total of 13 questions and the score for each question ranges from 1 to 4. The total score is 52 and higher scores indicate that the patient is more inclined to adopt telerehabilitation. This will involve analyzing the responses of participants to the questionnaire to determine if it accurately measures the intended construct. The study will also assess the internal consistency of the responses to determine if the scale produces consistent results when administered multiple times to the same group of patients.
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 May 2023
- Study start1 Aug 2023 (estimated)
- Primary completion1 Dec 2023 (estimated)
- Study completion1 Mar 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pulmonary DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 60 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Uskudar State Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Mustafa Hüseyin Temel, Uskudar State Hospital
- Investigators
- Mustafa H Temel, M.D., Principal investigator, Uskudar State Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05871710
- Sponsor's protocol ID
- TelePulm
- Status last verified
- May 2023
- First submitted
- 27 Apr 2023
- Last updated
- 23 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Individual participant data will be shared upon reasonable request by the co-responding author.
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validity and Reliability of the Turkish Version of the Tele-Pulmonary Rehabilitation Acceptance Scale
- ClinicalTrials.gov ID
- NCT05871710
- Acronym / sponsor ID
- TelePulm
- Conditions
- Pulmonary Disease, Telehealth, Pulmonary Rehabilitation
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Uskudar State HospitalOther government
- Study start
- 1 Aug 2023 (estimated)
- Primary completion
- 1 Dec 2023 (estimated)
- Study completion
- 1 Mar 2024 (estimated)
- First posted
- 23 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this research is to translate the Tele-Pulmonary Rehabilitation Acceptance Scale into Turkish and assess its reliability and accuracy.
Detailed description
The use of telehealth in pulmonary rehabilitation, also known as telerehabilitation, is a novel approach in healthcare practice. In order to effectively implement telerehabilitation programs, it is important to evaluate how potential users perceive and accept this new type of program. Thus, the aim of this research was to create a measuring tool that could assess the level of acceptance of telerehabilitation among healthcare providers and patients. A group of experts in pulmonary rehabilitation, telehealth, information technology, and scale development have reviewed and confirmed the content validity of the Tele-Pulmonary Rehabilitation Acceptance Scale. This scale is significant because it offers a consistent means of collecting data to measure the level of acceptance towards telerehabilitation among potential users. This study aims to translate and show the consistency and validity of the Tele-Pulmonary Rehabilitation Acceptance Scale in Turkish.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 1 Day
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Patients in need of pulmonary rehabilitation or already receiving pulmonary rehabilitation. | – | Other: Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale, Other: Scale Evaluation FormNative Turkish-speaking patients in need of pulmonary rehabilitation or already receiving pulmonary rehabilitation. |
| Health personnel working in the field of pulmonary rehabilitation. | – | Other: Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale, Other: Scale Evaluation FormNative Turkish-speaking health personnel working in the field of pulmonary rehabilitation. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Native Turkish-speaking patients in need of pulmonary rehabilitation and native Turkish-speaking healthcare professionals working in the field of pulmonary rehabilitation.
Key inclusion criteria (3 listed)
- Being a patient in need of pulmonary rehabilitation or a healthcare professional working in the field of pulmonary rehabilitation.
- Being a native Turkish speaker.
- Giving consent to participate in the study.
Key exclusion criteria (2 listed)
- Any disease or condition that prevents reading, understanding, or filling out forms.
- Not giving consent to participate in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Turkish version of the Tele-Pulmonary Rehabilitation Acceptance ScaleThe Tele-Pulmonary Rehabilitation Acceptance Scale is a measuring tool that assesses the level of acceptance towards telerehabilitation programs among healthcare providers and patients in the field of pulmonary rehabilitation. It is used to evaluate the attitudes, beliefs, and perceptions of potential users towards telerehabilitation, which is a form of healthcare delivery that utilizes telecommunication technology to provide remote rehabilitation services to patients. The scale is intended to provide a standardized data collection tool that can be used to measure the level of acceptance of telerehabilitation programs among different groups of potential users. This scale will be translated into Turkish by a researcher who has an advanced level of knowledge in English and whose native language is Turkish. | Other | Health personnel working in the field of pulmonary rehabilitation., Patients in need of pulmonary rehabilitation or already receiving pulmonary rehabilitation. |
| Scale Evaluation FormThe healthcare providers and the patients will be asked about their opinions on the scale's construction, usefulness, and scope using a 100 mm visual analog scale. | Other | Health personnel working in the field of pulmonary rehabilitation., Patients in need of pulmonary rehabilitation or already receiving pulmonary rehabilitation. |
Primary outcome
Validity and reliability of the Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale
Time frame: 1 day
The primary outcome is the overall validity and reliability of the Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale. This scale is a Likert scale with a total of 13 questions and the score for each question ranges from 1 to 4. The total score is 52 and higher scores indicate that the patient is more inclined to adopt telerehabilitation. This will involve analyzing the responses of participants to the questionnaire to determine if it accurately measures the intended construct. The study will also assess the internal consistency of the responses to determine if the scale produces consistent results when administered multiple times to the same group of patients.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2023.
- Individual participant dataSharing planned: Undecided. Individual participant data will be shared upon reasonable request by the co-responding author.
Related trials for Pulmonary Disease
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Non Small Cell Lung Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mustafa H Temel, M.D. principal investigator
Uskudar State Hospital
Questions about this trial
What is this clinical trial studying?
An observational study of Pulmonary Disease and Telehealth, run by Uskudar State Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 May 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Mustafa H Temel, M.D. (+905342714872, mhuseyintemel@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Validity and reliability of the Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2023.